SINAGRA, GIANFRANCO
 Distribuzione geografica
Continente #
NA - Nord America 3.295
AS - Asia 1.822
EU - Europa 1.642
SA - Sud America 564
AF - Africa 55
OC - Oceania 4
Totale 7.382
Nazione #
US - Stati Uniti d'America 3.166
SG - Singapore 780
RU - Federazione Russa 550
IT - Italia 460
BR - Brasile 453
CN - Cina 439
VN - Vietnam 264
DE - Germania 177
GB - Regno Unito 106
HK - Hong Kong 92
CA - Canada 81
IE - Irlanda 68
AR - Argentina 55
IN - India 42
PL - Polonia 42
FI - Finlandia 41
FR - Francia 41
MX - Messico 36
NL - Olanda 34
ZA - Sudafrica 34
TR - Turchia 31
ID - Indonesia 30
JP - Giappone 25
ES - Italia 24
SE - Svezia 24
UA - Ucraina 23
EC - Ecuador 22
PK - Pakistan 22
BD - Bangladesh 21
AT - Austria 18
IL - Israele 17
IQ - Iraq 16
LT - Lituania 15
CO - Colombia 13
BE - Belgio 10
UZ - Uzbekistan 10
AE - Emirati Arabi Uniti 7
KE - Kenya 7
SA - Arabia Saudita 7
VE - Venezuela 7
CH - Svizzera 5
CL - Cile 5
OM - Oman 5
EG - Egitto 4
NZ - Nuova Zelanda 4
PY - Paraguay 4
HN - Honduras 3
MA - Marocco 3
UY - Uruguay 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
JM - Giamaica 2
KW - Kuwait 2
NP - Nepal 2
PE - Perù 2
TT - Trinidad e Tobago 2
AL - Albania 1
AZ - Azerbaigian 1
BW - Botswana 1
EE - Estonia 1
GD - Grenada 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
PA - Panama 1
PH - Filippine 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TW - Taiwan 1
VC - Saint Vincent e Grenadine 1
YE - Yemen 1
Totale 7.382
Città #
Dallas 1.830
Singapore 426
Ashburn 222
Beijing 204
Ho Chi Minh City 98
Hong Kong 87
Los Angeles 87
Milan 70
Dublin 68
Chandler 60
Moscow 59
Munich 58
New York 58
São Paulo 46
Hanoi 45
Hefei 45
Rome 40
Warsaw 36
Santa Clara 35
The Dalles 35
Boardman 31
San Mateo 30
Brooklyn 28
Frankfurt am Main 26
Johannesburg 24
Tokyo 24
Ottawa 23
Beauharnois 22
Fairfield 22
Houston 21
Montreal 21
Pisa 21
Buffalo 20
Cambridge 20
Denver 20
London 20
Seattle 20
Poplar 19
Chennai 17
Lappeenranta 17
Nuremberg 17
Portsmouth 17
Boston 16
Orem 16
West Jordan 16
Istanbul 15
Stevenage 14
Tel Aviv 14
Bologna 13
Brasília 13
Helsinki 13
Krefeld 13
Mexico City 13
Phoenix 13
San Francisco 13
Wilmington 13
Atlanta 12
Belo Horizonte 12
Querétaro 12
Rio de Janeiro 12
Amsterdam 11
Ankara 11
Biên Hòa 11
Florence 11
Haiphong 11
Lawrence 11
Turku 11
Bad Bellingen 10
Chicago 10
Dong Ket 10
Porto Alegre 10
Stockholm 10
Tashkent 10
Genoa 9
Guarulhos 9
Manchester 9
New Delhi 9
Turin 9
Bari 8
Brussels 8
Buenos Aires 8
Da Nang 8
Livorno 8
Nocera Inferiore 8
Washington 8
Guayaquil 7
Nairobi 7
Ninh Bình 7
Vienna 7
Assago 6
Cape Town 6
Guangzhou 6
Lucca 6
Mykolayiv 6
Naples 6
Rawalpindi 6
Redondo Beach 6
Ribeirão Preto 6
Salvador 6
San Diego 6
Totale 4.664
Nome #
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 657
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 421
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 290
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 247
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 223
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 219
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 217
[Ten perspectives for research and innovation in cardiac amyloidosis] 206
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 196
[Transcatheter devices for chronic heart failure: state of the art] 190
Cardiovascular Death Risk in Recovered Mid-Range Ejection Fraction Heart Failure: Insights From Cardiopulmonary Exercise Test 187
Exploring the Prognostic Performance of MECKI Score in Heart Failure Patients with Non-Valvular Atrial Fibrillation Treated with Edoxaban 179
Roles of periodic breathing and isocapnic buffering period during exercise in heart failure 173
Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score 166
Valvular heart disease in patients with cardiac amyloidosis 164
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 164
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 160
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 159
Increased serum uric acid level predicts poor prognosis in mildly severe chronic heart failure with reduced ejection fraction. An analysis from the MECKI score research group 157
Sex differences in the prognostic role of achieving target doses of heart failure medications: Data from the Swedish Heart Failure Registry 154
Percorsi diagnostico-terapeutici assistenziali per i pazienti con amiloidosi cardiaca – Documento di consenso SIC/ANMCO. A cura della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 154
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction 154
Inferior Vena Cava Edge Tracking Echocardiography: A Promising Tool with Applications in Multiple Clinical Settings 150
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 146
Early diagnosis, disease stage and prognosis in wild‐type transthyretin amyloid cardiomyopathy: The DIAMOND study 143
Association between implantable defibrillator-detected sleep apnea and atrial fibrillation: The DASAP-HF study 141
Heart failure patients with improved ejection fraction: Insights from the MECKI score database 140
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 138
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies 134
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set 130
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study 129
Pressure-volume relationship by pharmacological stress cardiovascular magnetic resonance 122
The chronic heart failure evolutions: Different fates and routes 118
Global Right Heart Assessment with Speckle-Tracking Imaging Improves the Risk Prediction of a Validated Scoring System in Pulmonary Arterial Hypertension 116
Change in prevalence of ATTR variants in Italy: results from a national survey 109
Gamma-glutamyltransferase independently predicts mortality and hospitalization for heart failure in cardiac transthyretin amyloidosis 109
Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension 106
Myocarditis and pericarditis during COVID-19 pandemic: a study of the Italian Society of Cardiology 106
Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With Tafamidis 103
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 101
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 97
Cardiac amyloidosis: when to suspect and how to confirm 95
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 91
Tafamidis in the Treatment of ATTR-related Cardiomyopathy 67
Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin Cardiomyopathy 24
Totale 7.452
Categoria #
all - tutte 37.161
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.161


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021101 0 0 0 0 0 0 0 0 48 5 30 18
2021/2022174 19 25 2 19 0 6 19 25 10 28 7 14
2022/2023204 12 21 3 15 22 23 5 23 52 1 17 10
2023/2024332 10 7 39 23 5 16 13 27 43 33 33 83
2024/20251.828 31 81 137 52 112 90 243 397 160 70 265 190
2025/20264.813 322 973 1.817 907 698 96 0 0 0 0 0 0
Totale 7.452